Aequus Pharmaceuticals (TSX-V: AQS, OTCQB: AQSZF)
is a rapidly growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus’
sales and marketing efforts are based in Canada, targeting highly specialized therapeutic areas including neurology, ophthalmology and transplant.
Aequus is developing a pipeline of products in neurology and psychiatry with a goal of addressing the need for improved medication adherence
through enhanced delivery systems. Aequus intends to commercialize its internal programs in Canada and to establish strategic partnerships
to accelerate and maximize the potential of its product candidates worldwide.

Aequus is developing a pipeline of prescription medications in neurology and psychiatry and that address current delivery and compliance
challenges....